EMPLOYMENT OF ZOLADEX, A SYNTHETIC AGONIST OF GNRH, IN THE MANAGEMENTOF BREAST-CANCER PATIENTS WITH METASTASES IN THE LUNGS OCCURRING AFTER PREVIOUS RADICAL TREATMENT
Nn. Antonenkova et al., EMPLOYMENT OF ZOLADEX, A SYNTHETIC AGONIST OF GNRH, IN THE MANAGEMENTOF BREAST-CANCER PATIENTS WITH METASTASES IN THE LUNGS OCCURRING AFTER PREVIOUS RADICAL TREATMENT, Annals of oncology, 9, 1998, pp. 698-698